MultiPoint Pacing Post Market Study

This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful SJM CRT MP device implant from up to 140 centers undergoing CRT implantation. Any patient who received a market approved SJM Quadra Allure MP, Quadra Assura MP, or newer SJM CRT MP device is eligible for enrollment in the study. MPP programming guidance will be specified in the protocol. Patients will be followed for 12 months after implant. Data will be collected at Baseline (within 30 days prior to implant), Post-Implant (within 30 days following successful CRT device implant), 3, 6, 12 months and during any unscheduled follow-up visit. Enrollment of the study is expected to require approximately 24 months. The anticipated duration of this study is 42 months, depending on the rate of enrollment. Devices used: Market-approved SJM Quadra Allure MP, Quadra Assura MP

You may be eligible for this study if you meet the following criteria:

• Conditions: TBD, tbd, tbd
• Age: 99 years or below
• Gender: All